A stochastic inventory model of COVID-19 and robust, real-time identification of carriers at large and infection rate via asymptotic lawsResearch article Published on 2023-01-012022-10-05 Journal: European Journal of Operational Research [Category] 변종, [키워드] affecting Asymptomatic asymptotic Care carrier COVID-19 COVID-19 incidence COVID-19 pandemic Critical data-driven deaths distribution Epidemic modeling Evolution fraction Health incidence infection rate Little's law management manifested Measures National Operations management under uncertainty OR in health services Outbreaks Patient Perspective profiles provide random Randomly reconstructed robust scaled Spread symptomatic carrier the disease the mean the SARS-CoV-2 trajectory variable variables [DOI] 10.1016/j.ejor.2021.12.037 [Article Type] Research article
Impact of SARS-CoV-2 variants on mobility and air pollution in the United KingdomArticle Published on 2022-12-102022-11-16 Journal: The Science of the total environment [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] activity affecting Algorithm Alpha baseline baseline level baseline levels contagiousness COVID-19 COVID-19 case death Delta event Government Immunity Impact Increases measure NO(2) normality Pollution prevalent Public public health reduced remained Result returned SARS-CoV-2 variant significant increase significantly social contact Spread Traffic Traffic. United Kingdom variant variants virus wildtype [DOI] 10.1016/j.scitotenv.2022.158279 PMC 바로가기
COVID-19 treatments approved in the European Union and clinical recommendations for the management of non-hospitalized and hospitalized patientsArticle Published on 2022-12-012022-11-15 Journal: Annals of Medicine [Category] COVID19(2023년), SARS, 진단, 치료제, [키워드] addition affecting alleviate antiviral medication antiviral medicine approved Baricitinib Care caused Clinical practice clinical recommendations Community courses COVID-19 COVID-19 pandemic COVID-19 patient COVID-19 treatment COVID-19 treatments Critical deaths develop disease disorder drug Dyspnea effective effective drugs European European Medicines Agency European Union Evidence guidelines. Health healthcare hospital Hospitalization Hospitalized hospitalized patient hypoxia Intervention involved life-threatening lung involvement management Mild moderate molnupiravir monoclonal antibodies monoclonal antibody Most patient Multiorgan dysfunction New outcome public health recommendation Remdesivir Respiratory failure rheumatoid arthritis SARS-CoV-2 Septic shock severe symptom Symptom the disease the patient therapy Thromboembolism Tocilizumab treat Treatment treatment strategy union vaccination [DOI] 10.1080/07853890.2022.2133162 PMC 바로가기
Sensitive detection of SARS-CoV-2 molecular markers in urban community sewersheds using automated viral RNA purification and digital droplet PCRArticle Published on 2022-11-152022-11-15 Journal: The Science of the total environment [Category] COVID19(2023년), SARS, 바이오마커, 치료기술, [키워드] affecting approach automated Care Community correlation COVID-19 COVID-19 case detection of marker Detroit disadvantage Effectiveness Epidemiology faster Final handling Health identify inhibitor Local marker molecular number of sample outbreak PCR PerkinElmer Prevent Promega public health authority purification required RNA RNA purification SARS-CoV-2 sensitive sensitivity Standard state the SARS-CoV-2 virus Thermofisher time-consuming Viral RNA Volume wastewater Wastewater. [DOI] 10.1016/j.scitotenv.2022.157547 PMC 바로가기
Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodiesArticle Published on 2022-11-082022-11-15 Journal: Scientific Reports [Category] SARS, 치료기술, [키워드] acute respiratory syndrome administration affecting analysis Analysis anti-RBD IgG antibody anti-SARS-CoV-2 AUC automated binding antibody booster clinical settings Cohort collected Control coronavirus correlation COVID-19 cutoff value demonstrated Effectiveness Genscript gold standard Immunity immunoassay in both groups infected patient Mindray NAb neutralization Neutralization assay neutralization test neutralizing antibody population level protective immunity provide pseudovirus R 2 Rapid receiver operating characteristic Research ROC ROC Curve Sample SARS-CoV-2 SARS-CoV-2 infected patient second dose sensitivity shown significantly specificity subjects sVNT sVNT assay symptoms onset tested threshold vaccinated individual Vaccine virus neutralization test was performed [DOI] 10.1038/s41598-022-21317-x PMC 바로가기
Viral load dynamics of SARS-CoV-2 Delta and Omicron variants following multiple vaccine doses and previous infectionArticle Published on 2022-11-072022-11-16 Journal: Nature Communications [Category] SARS, 변종, [키워드] affected affecting booster can be used COVID-19 cycle threshold Delta Delta wave demonstrated effective Effectiveness implication individuals Infection Laboratory less morbidity and mortality natural infection omicron pathogen public health qRT-PCR reduce SARS-CoV-2 significantly sustained the vaccine Transmissibility vaccination Vaccine vaccine dose variant Viral load while [DOI] 10.1038/s41467-022-33096-0 PMC 바로가기
Environmental pathways affecting gene expression (E.PAGE) as an R package to predict gene-environment associationsArticle Published on 2022-11-042022-11-16 Journal: Scientific Reports [Category] 유전자 메커니즘, [키워드] Abstract affecting articles association biological processe Cell comprehensive resource COVID-19 criteria curated database dataset develop diabetes differentially expressed gene dysregulated enriched biological processes environmental factor environmental factors Gene Expression Gene Expression Omnibus Genes Infection initial Interaction lung cancer pathway predict R package retrieved rheumatoid arthritis selected signature smoking statistical analysis statistically tested [DOI] 10.1038/s41598-022-21988-6 PMC 바로가기
Mortality and Deep Vein Thrombosis in the Gamma Variant of Covid 19 and Lung InjuryArticle Published on 2022-11-032022-11-16 Journal: Vascular Health and Risk Management [Category] SARS, 변종, [키워드] affecting Analysis chi-square test clinical suspicion Coagulation complications conducted COVID-19 Critically ill patient deep Deep vein Deep vein thrombosis determine DVT Factor Fisher Gamma greater had more hospital infected individual inhibitor intensive care involved lesion less lung mechanism medical record Mortality occurred Patient patients with SARS-CoV-2 positive Prevalence pulmonary pulmonary injury Pulmonary thrombosis. Retrospective study SARS-CoV-2 disease severe lung injury t -test thrombosis thrombotic event Treatment two group variant Vein Venous thrombosis [DOI] 10.2147/VHRM.S367930 PMC 바로가기
Retrospective analysis of SARS-CoV-2 omicron invasion over delta in French regions in 2021-22: a status-based multi-variant modelArticle Published on 2022-11-032022-11-16 Journal: BMC Infectious Diseases [Category] SARS, 변종, [키워드] affecting Analysis analysis approach average baseline level carried caused circulation conducted cross deaths disease epidemiological events expressed France French Generation time globe heterogeneity immunized incidence Invasion investigated knowledge Multi-variant model omicron outbreak parameter rapidly spreading disease Region regions replaced reported SARS-CoV-2 SARS-COV-2 infection Spread Transmissibility. transmission potential Uncertainty variant [DOI] 10.1186/s12879-022-07821-5 PMC 바로가기
Prevalence of peripheral neuropathy and myopathy in patients post-COVID-19 infectionArticle Published on 2022-11-012022-11-16 Journal: International journal of rheumatic diseases [Category] SARS, 치료기술, [키워드] acute respiratory syndrome addition affecting All participant asymptomatic patient both group caused clinical examination Clinical signs Complete complications control group controls COVID-19 COVID-19 infection Department Electrophysiology Epidemic evaluate feature Gender groups healthy volunteer history Hospitalization Infection involved laboratory measure life-threatening long-lasting multiple organs Myopathy nervous system Patient patients performed Peripheral Neuropathy post-COVID-19 patient Prevalence problem recent respiratory symptom risk factor Risk factors Risk factors. SARS-CoV-2 serum creatine phosphokinase significant difference symptomatic without symptom [DOI] 10.1111/1756-185X.14409 PMC 바로가기